Grove Bank & Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
CIM
MPWT
MSV
BRCM
GI
CI
VCM
HWA
FFA
ANBT
Grove Bank & Trust's RMD Position: Q3 2026 in Review
Grove Bank & Trust held its ResMed (RMD) position steady in Q3 2026 at 95 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #559.
Grove Bank & Trust first reported a position in RMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $26K in Q3 2025. 22 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Grove Bank & Trust held 95 shares of ResMed worth $21K as of Q3 2026.
- Grove Bank & Trust left its ResMed share count unchanged in Q3 2026.
- ResMed made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #559 holding.
- Grove Bank & Trust first reported a position in ResMed in Q1 2023 and has held it in 13 quarters since.
- Grove Bank & Trust's ResMed position peaked at $26K in Q3 2025.
- 22 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.